Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AtriCure Inc Issues Q4, FY 2012 Revenue Guidance In Line With Analysts' Estimates


Monday, 7 Jan 2013 07:00am EST 

AtriCure Inc announced that for fourth quarter of 2012, it expects revenue to be approximately $18.4 million, reflecting growth of approximately 9.5% over the fourth quarter of 2011. For fiscal 2012, it expects revenue to be $70.2 million, reflecting year over year growth of 9.1% over full year 2011. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $18.5 million for fourth quarter of 2012 and revenue of $70.4 million for fiscal 2012. 

Company Quote

15.8
0.06 +0.38%
22 Aug 2014